A carregar...
Der Einsatz von Immuncheckpoint-Inhibitoren im onkologischen Alltag
BACKGROUND: The advent of immune checkpoint inhibitors has dramatically changed the treatment landscape of many different tumor types. In the clinical routine, humanized antibodies against the immune checkpoints cytotoxic T‑lymphocyte associated protein 4 (CTLA-4) and programmed cell death 1/program...
Na minha lista:
| Publicado no: | Z Rheumatol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Medizin
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7653782/ https://ncbi.nlm.nih.gov/pubmed/32936368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00393-020-00876-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|